TDOC:NYE-Teladoc Inc. (USD)

EQUITY | Health Information Services | New York Stock Exchange

Last Closing

USD 9.73

Change

+0.16 (+1.67)%

Market Cap

USD 0.81B

Volume

0.01B

Analyst Target

USD 241.46
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Teladoc Inc provides telehealth platform, delivering on-demand healthcare anytime, anywhere, via mobile devices, the internet, video and phone.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-30 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
SOLV Solventum Corp.

N/A

USD 10.78B
DOCS Doximity Inc

N/A

USD 6.81B
WEAV Weave Communications Inc

N/A

USD 0.81B
MPLN MultiPlan Corporation

N/A

USD 0.16B
AMWL American Well Corp

N/A

USD 0.12B
OWLT Owlet Inc

N/A

USD 0.05B
PHR Phreesia Inc

N/A

N/A
FOXO FOXO Technologies Inc.

N/A

N/A
EVH Evolent Health Inc

N/A

N/A
VEEV Veeva Systems Inc Class A

N/A

N/A

ETFs Containing TDOC

RWM ProShares Short Russell20.. 0.00 % 0.95 %

N/A

USD 0.14B
CCON 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -54.85% 30% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -54.85% 30% F 2% F
Trailing 12 Months  
Capital Gain -64.94% 40% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -64.94% 40% F 2% F
Trailing 5 Years  
Capital Gain -86.38% 25% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -86.38% 25% F 2% F
Average Annual (5 Year Horizon)  
Capital Gain -12.04% 55% F 8% B-
Dividend Return -12.04% 55% F 7% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 86.08% 18% F 8% B-
Risk Adjusted Return -13.99% 55% F 21% F
Market Capitalization 0.81B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Health Information Services) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.